Specialised medical large language model
Guiding and auditing causal mechanistic pathways with traceability at every step.
An LLM trained, tested and guided on the aggregated trends of 150M+ blood result records and clinical profiles.

Specialised reasoning. Any frontier model.
Bayesian differential diagnosis
Coexists with frontier models
Agents
Ada 1.0 + Florence 1.0
Specialised AI Agents with Mechanistic Explainability.
Florence 1.0 and Ada 1.0 are AlgocyteGPt's specialised agentic large language models. Founded on Bayesian inference, they help create ultra-personalised questionnaires from all the multimodal data sources collected across the Algocyte ecosystem, to support differential diagnosis and build a clinical digital twin over time.
A case presentation is worked through the full pipeline and returned as a grounded, source-cited assessment with a ranked differential coded in ICD-10, with phecodes and SNOMED CT on top, for review by the clinician in charge. The approach draws on longitudinal disease-signature research↗.
Ada and Florence are currently in alpha, being rolled out internally with a focus group for testing purposes, and are subject to regulatory compliance in different jurisdictions. All connections are secure, under ISO 27001 and Cyber Essentials Plus.
Better questions. A continuing diagnostic cycle.

Automatically generated, ultra-personalised questionnaires combine medical data and blood results with patient responses, lifestyle and wearable information. They are fine-tuned to investigate diagnostic directions suggested by the available evidence.
Ada and Florence never interact with the patient directly, other than through questions vetted and supervised by clinicians. Clinicians remain in full control: they can tweak, delete or add anything, and use two-way communication to enrich the medical record.
The answers are attached to each blood test result to enrich it and inform the next cycle of tests and questions, in an ongoing cycle of continuous care.
Symptoms, lifestyle and blood factors. Together.
No single reading tells the whole story. AlgocyteGPt™ reasons over what the individual reports, everyday context and blood results in one longitudinal record. Uploaded and scanned medical reports become structured, machine-readable data, with the original documents and available sources retained.
Symptoms and wellbeing
Lifestyle and daily context
Blood factors and records



Traceable at every step.
Every step of the reasoning can be followed back to the data, the source and the model that produced it.
Data provenance
Auditable pathways
Model independent
Clinician control
AlgocyteGPt™ provides clinician-facing decision support and does not replace clinical assessment. The 150M+ figure refers to aggregated trends in blood result records with clinical profiles, not to access to individual records. Module-specific intended use, availability and regulatory status apply and differ between jurisdictions.
Regulatory informationAlgocyte ecosystem.
Algocyte HealthHub™
The AI platform where AlgocyteGPt™ works.
Algocyte Proxima™
Ultra-portable blood testing device.
Algocyte CellView™
Digital pathology inspection module.
Consumables
Blood panel consumables.
Technology
Physics-informed AI and causal biological models.
Use Cases
Where the Algocyte ecosystem is applied.